EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pemetrexed induces ROS generation and cellular senescence by attenuating TS ‐mediated thymidylate metabolism to reverse gefitinib resistance in NSCLC

Yun Chen, Chen Zhang, Shidai Jin, Jun Li, Jiali Dai, Zhihong Zhang, Renhua Guo iD

Journal of Cellular and Molecular Medicine · 2023

DOI: 10.1111/jcmm.17799 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2023. Verfasst von Yun Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Jiangsu Province People's Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR‐TKI) are strongly recommended for non‐small‐cell lung cancer (NSCLC) patients harbouring active EGFR mutations, while drug resistance makes exploring resistance mechanisms and seeking effective therapeutic strategies urgent endeavours. Thymidylate synthetase (TYMS or TS) is a dominant enzyme in thymidylate nucleotide metabolism. In this study, we found a positive correlation between TS expression and overall survival (OS) and disease‐free survival (DFS) in lung adenocarcinoma. The examination of gene sets from 140 NSCLC patients received EGFR‐TKI therapy demonstrated a negative correlation between high TS expression and the efficacy of EGFR‐TKI therapy. 24 tissue specimens from NSCLC patients exhibited upregulated TS mRNA expression in NSCLC patients resistant to gefitinib. The NSCLC cell PC9 and HCC827 sensitive to gefitinib and relatively resistant PC9/GR and HCC827/GR cells were used to demonstrate the knockdown of TS restored the sensitivity of resistant cells to gefitinib. Furthermore, pemetrexed effectively suppressed TS‐mediated thymidylate metabolism and induced ROS generation, DNA damage and cellular senescence, thereby hampering cancer progression and restoring sensitivity to gefitinib. Our findings illuminate the potential mechanism of TS‐triggered gefitinib resistance and indicate inhibition of TS by pemetrexed can potentiate the effect of gefitinib in NSCLC. Pemetrexed combined with gefitinib has potent anti‐progression potential in gefitinib‐resistant NSCLC. This study suggests that NSCLC patients with both high TS expression and EGFR‐driving mutations might benefit more from a combination strategy of EGFR‐TKI and pemetrexed‐based chemotherapy than EGFR‐TKI monotherapy, which has profound clinical implications and therapeutic value.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsHumansGefitinibPemetrexedReactive Oxygen SpeciesErbB ReceptorsQuinazolinesDrug Resistance, NeoplasmCell Line, TumorCellular SenescenceMutationProtein Kinase Inhibitors

Substanzen

GefitinibPemetrexedReactive Oxygen SpeciesErbB ReceptorsQuinazolinesProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Oncology, Jiangsu Province People's Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, China.
  • Department of Pathology, Jiangsu Province People's Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, China.

ORCID-Profile: Renhua Guo

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Chen, Y., Zhang, C., Jin, S., Li, J., Dai, J., Zhang, Z., & Guo, R. (2023). Pemetrexed induces ROS generation and cellular senescence by attenuating TS ‐mediated thymidylate metabolism to reverse gefitinib resistance in NSCLC. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.17799

Vancouver

Chen Y, Zhang C, Jin S, Li J, Dai J, Zhang Z, et al. Pemetrexed induces ROS generation and cellular senescence by attenuating TS ‐mediated thymidylate metabolism to reverse gefitinib resistance in NSCLC. Journal of Cellular and Molecular Medicine. 2023. doi:10.1111/jcmm.17799

BibTeX
@article{Chen2023,
  author = {Chen, Yun and Zhang, Chen and Jin, Shidai and Li, Jun and Dai, Jiali and Zhang, Zhihong and Guo, Renhua},
  title = {Pemetrexed induces ROS generation and cellular senescence by attenuating TS ‐mediated thymidylate metabolism to reverse gefitinib resistance in NSCLC},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2023},
  doi = {10.1111/jcmm.17799}
}
Kostenlos starten →